Study Links Sleep Problems to Increased Severe Asthma Risk in Children

Approximately 30 to 40 percent of children with asthma face sleep issues due to symptoms such as coughing and wheezing. These sleep disturbances elevate the likelihood of severe asthma exacerbations, which can lead to hospitalizations or emergency department visits, thus placing a significant strain on patients, families, and the healthcare system. Despite these risks, there is limited research focused on identifying children with concurrent asthma and sleep problems who may benefit from targeted preventive interventions.

Key findings from the study indicate that boys with asthma who experience fragmented sleep are at an increased risk for severe asthma attacks, particularly if they have a history of such attacks. Conversely, children receiving treatment for sleep disturbances have a lower risk of future severe asthma events.

To enhance early identification of children vulnerable to severe asthma attacks, the researchers developed a prognostic model that integrates accessible medical health record data and sleep study information. This model shows greater accuracy compared to current practices that primarily rely on the history of severe asthma attacks.

Healthcare providers are encouraged to consider referring children with asthma and sleep-related issues for sleep studies. This approach could facilitate the early identification of at-risk children who may benefit from preventive sleep interventions aimed at reducing the occurrence of severe asthma attacks.

Looking ahead, the research team plans to further investigate the predictive value of combining electronic health record data, sleep parameters, and microstructure analysis to refine their prognostic algorithms. Additionally, they will assess the feasibility and initial effectiveness of sleep-related medications identified in the study as a preventive strategy for reducing severe asthma risks among at-risk pediatric patients.

This study received partial support from grants from the National Institutes of Health, USA, including K01HL166436 and R03HS029088.